Holen Sie sich die Stockscreener-App
19.21
3.71%
-0.74
Schlusskurs vom Vortag:
$19.95
Offen:
$19.86
24-Stunden-Volumen:
852.80K
Relative Volume:
0.45
Marktkapitalisierung:
$1.01B
Einnahmen:
$59,000
Nettoeinkommen (Verlust:
$-84.74M
KGV:
-3.2994
EPS:
-5.8222
Netto-Cashflow:
$-59.69M
1W Leistung:
+1.96%
1M Leistung:
+46.64%
6M Leistung:
+13.33%
1J Leistung:
+292.04%
1-Tages-Spanne:
$18.42
$20.45
1-Wochen-Bereich:
$18.36
$20.65
52-Wochen-Spanne:
$4.61
$24.27
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Compare AVTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
19.21 | 1.01B | 59,000 | -84.74M | -59.69M | -5.8222 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-09 | Eingeleitet | Wolfe Research | Outperform |
| 2026-04-06 | Eingeleitet | Citizens | Mkt Outperform |
| 2026-02-02 | Eingeleitet | Guggenheim | Buy |
| 2025-12-18 | Eingeleitet | Mizuho | Outperform |
| 2025-09-17 | Bestätigt | H.C. Wainwright | Buy |
| 2025-09-05 | Eingeleitet | TD Cowen | Buy |
| 2025-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Jefferies | Buy |
| 2025-03-25 | Eingeleitet | Stifel | Buy |
| 2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum - The Manila Times
Millennium Group (AVTX) reports shared control of 9,857 Avalo shares (Jul 2026) - Stock Titan
AVTX Initiates Coverage by Leerink Partners -- Rating Set to Out - GuruFocus
Leerink initiates Avalo Therapeutics stock with outperform rating By Investing.com - Investing.com Australia
Leerink Partners Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $38 - Moomoo
Leerink initiates Avalo Therapeutics stock with outperform rating - Investing.com
Avalo Therapeutics CLO Paul Varki sells $1.5m shares after option exercise - Investing.com
Certain Restricted Stock Units of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. - marketscreener.com
Certain Options of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. - marketscreener.com
AVTXAvalo Therapeutics Inc Latest SEC Filings - Finviz
AVTX News | AVALO THERAPEUTICS INC (NASDAQ:AVTX) - ChartMill
Avalo Therapeutics (AVTX) director receives fully vested options grant - Stock Titan
Avalo Therapeutics (AVTX) CMO exercises options, sells 4,654 pre-planned shares - Stock Titan
Avalo Therapeutics (AVTX) director granted fully vested options on 1,080 shares - Stock Titan
Avalo Therapeutics (AVTX) director receives grant of 1,105 stock options - Stock Titan
Why Did AVTX Stock Surge 45% In Pre-Market Today? - Stocktwits
Price to earnings forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Enterprise value to revenue forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Price to sales forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Enterprise value to EBITDA forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Price to book forward of Avalo Therapeutics, Inc. – NASDAQ:AVTX - TradingView
Price to sales forward of Avalo Therapeutics Inc – LSX:A3E2FR - TradingView
Avalo Therapeutics (AVTX) Is Up 12.9% After Broad Russell Index AdditionsWhat's Changed - Yahoo Finance
Avalo Therapeutics Inc Actuals & Estimates (NASDAQ:AVTX) - TradingView
Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 2500 Growth Benchmark - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 2000 Index - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 2000 Value Benchmark - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 2000 Growth Benchmark - marketscreener.com
Why Avalo Therapeutics (AVTX) Is Up 12.9% After Broad Russell Index Inclusion And Pipeline Progress - Sahm
Avalo Therapeutics, Inc.(NasdaqCM: AVTX) added to Russell 3000E Growth Benchmark - marketscreener.com
Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Avalo Therapeutics Edges Higher, Testing Key Resistance at $19.11MFI Oversold - dars.gov.et
Avalo Therapeutics (AVTX) Joins Russell 2000 and 3000 Indices - GuruFocus
Avalo Therapeutics added to Russell 2000 and 3000 indexes By Investing.com - Investing.com Nigeria
Avalo Therapeutics added to Russell 2000 and 3000 indexes - Investing.com
Avalo Therapeutics to Join Russell 2000, Russell 3000 Indexes - marketscreener.com
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes - GlobeNewswire
AVTX Forecast — Price Target — Prediction for 2027 - TradingView
Avalo Therapeutics CMO Mittie Doyle sells $26,100 of shares - Investing.com UK
Avalo Therapeutics CMO Mittie Doyle sells $26,100 of shares By Investing.com - Investing.com Australia
Avalo Therapeutics Inc Actuals & Estimates (FWB:C6K0) - TradingView
Form 4 Avalo Therapeutics Inc For: 25 June By Investing.com - Investing.com Australia
Avalo Therapeutics (AVTX) CMO trades 1,450 shares in 10b5-1 exercise-and-sell - Stock Titan
Avalo Therapeutics (AVTX) director awarded 40,200 stock options at $17.83 strike - Stock Titan
[Form 3] Avalo Therapeutics, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doyle Mittie - Moomoo
Avalo Therapeutics Adds Independent Director Ron Philip - The Globe and Mail
Form 8K Avalo Therapeutics Inc For: 23 June By Investing.com - Investing.com Nigeria
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):